Dr. Cristianne Rijcken is Chief Scientific Officer and a Founder of Cristal Therapeutics.

Dr. Rijcken’s PhD thesis provided a strong basis for Cristal Therapeutics and she was awarded multiple grants and prizes including the Simon Stevin Gezel Award in 2008 and the Knowledge for Growth Inspiring Young Scientist Award in 2014. She has authored over 30 scientific publications and is named on all Cristal Therapeutics’ patents and patent applications.

In recognition of Dr Rijcken’s innovative approach, strength in translational research and her entrepreneurial attitude, she was awarded the Limburg Businesswoman of the Year in 2017.

Dr. Rijcken is pharmacist by training and holds a PhD degree in Pharmaceutics from Utrecht University, The Netherlands.

Dr. Werner Cautreels was President and CEO of Selecta Biosciences (Boston and Moscow) from July 2010 until his retirement in December 2018. He is now pursuing a portfolio career.

Previously, he served as Global CEO of Solvay Pharmaceuticals until it was acquired by Abbott Laboratories in 2010. Prior to joining Solvay heworked at Sanofi, Sterling Winthrop and Nycomed-Amersham in a variety of R&D management positions in Europe and in the United States.

Dr. Cautreels was a Director of Innogenetics NV (Gent, Belgium) and of Arqule Inc. (Woburn, MA, USA), and was until April 2019 a Director, and Chair of the Audit Committee of Galapagos NV (Mechelen, Belgium). He was also the President of the Belgian Chamber of Commerce for Russia.

He received his Ph.D. in Chemistry from the University of Antwerp, Belgium and an Executive MBA from Harvard Business School.